Johnson Fistel, PLLP Investigates Claims on Behalf of Alto Neuroscience, Inc. Long-Term Shareholders

Johnson Fistel, PLLP is investigating potential claims on behalf of Alto Neuroscience, Inc. (NYSE: ANRO) shareholders against certain of its officers and directors who may have breached the fiduciary duties they owed to the Company.

A recently filed federal securities fraud class action complaint alleges that Alto Neuroscience, Inc., through certain of its officers, made materially false and misleading statements regarding the Company’s business, operations, and prospects. Specifically, the complaint alleges that Defendants made false and/or misleading statements and/or failed to disclose that ALTO-100 was less effective in treating MDD than Defendants had led investors to believe, that ALTO-100’s clinical, regulatory, and commercial prospects were overstated, and that as a result, Alto’s business and financial prospects were overstated. Consequently, the Company’s public statements were materially false and misleading at all relevant times.

About Johnson Fistel, PLLP: Johnson Fistel, PLLP is a nationally recognized shareholder rights law firm representing individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit https://www.johnsonfistel.com.

Attorney advertising. Past results do not guarantee future outcomes. Services may be performed by attorneys in any of our offices. Johnson Fistel, PLLP has paid for the dissemination of this promotional communication, and Frank J. Johnson is the attorney responsible for its content.

Contact:
Johnson Fistel, PLLP
501 W. Broadway, Suite 800, San Diego, CA 92101
James Baker, Investor Relations or Frank J. Johnson, Esq.
(619) 814-4471 | jimb@johnsonfistel.com or fjohnson@johnsonfistel.com